PetIQ (PETQ)
(Delayed Data from NSDQ)
$30.87 USD
0.00 (0.00%)
Updated Oct 7, 2024 04:00 PM ET
After-Market: $30.88 +0.01 (0.03%) 5:06 PM ET
1-Strong Buy of 5 1
B Value A Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$30.87 USD
0.00 (0.00%)
Updated Oct 7, 2024 04:00 PM ET
After-Market: $30.88 +0.01 (0.03%) 5:06 PM ET
1-Strong Buy of 5 1
B Value A Growth C Momentum A VGM
Zacks News
High Tide Inc. (HITI) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
High Tide (HITI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Wall Street Analysts Believe PetIQ (PETQ) Could Rally 58.64%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at a 58.6% upside potential for PetIQ (PETQ). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Are Investors Undervaluing PetIQ (PETQ) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
PetIQ (PETQ) Broadens Minties Line With Large Dogs Dental Treats
by Zacks Equity Research
PetIQ (PETQ), with a focus on affordability and natural ingredients, is well-positioned to meet the evolving needs of pet owners and continue its growth trajectory in the pet wellness market.
PetIQ (PETQ) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
PetIQ (PETQ) delivered earnings and revenue surprises of 58.62% and 15.93%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Walgreens (WBA) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Strength in U.S. Healthcare and International businesses is likely to drive Walgreens' (WBA) first-quarter 2024 performance.
PETQ or ABT: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PETQ vs. ABT: Which Stock Is the Better Value Option?
Fast-paced Momentum Stock PetIQ (PETQ) Is Still Trading at a Bargain
by Zacks Equity Research
PetIQ (PETQ) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Should Value Investors Buy PetIQ (PETQ) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
PETQ vs. ABT: Which Stock Is the Better Value Option?
by Zacks Equity Research
PETQ vs. ABT: Which Stock Is the Better Value Option?
PetIQ (PETQ) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
by Zacks Equity Research
PetIQ (PETQ) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Are Investors Undervaluing PetIQ (PETQ) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
PETQ vs. ABT: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
PETQ vs. ABT: Which Stock Is the Better Value Option?
Should Value Investors Buy PetIQ (PETQ) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
PETQ or LMAT: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PETQ vs. LMAT: Which Stock Is the Better Value Option?
Why Fast-paced Mover PetIQ (PETQ) Is a Great Choice for Value Investors
by Zacks Equity Research
PetIQ (PETQ) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
PetIQ (PETQ) Moves 5.7% Higher: Will This Strength Last?
by Zacks Equity Research
PetIQ (PETQ) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
PetIQ (PETQ) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
PetIQ (PETQ) delivered earnings and revenue surprises of 76.92% and 14.72%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
PetIQ (PETQ) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
PetIQ (PETQ) delivered earnings and revenue surprises of 28.57% and 4.23%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Boston Scientific (BSX) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Boston Scientific (BSX) delivered earnings and revenue surprises of 9.30% and 7.61%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
PetIQ (PETQ) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
PetIQ (PETQ) delivered earnings and revenue surprises of 37.50% and 4.02%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate PetIQ (PETQ) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
PetIQ (PETQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SurModics (SRDX) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
SurModics (SRDX) delivered earnings and revenue surprises of 21.88% and 3.09%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Is GN Store Nord (GNNDY) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
PETQ vs. BSX: Which Stock Is the Better Value Option?
by Zacks Equity Research
PETQ vs. BSX: Which Stock Is the Better Value Option?